Clinical Trial Update: Effect of Zoledronic Acid as Anti-Cancer Treatment in Metastatic Breast Cancer Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating zoledronic acid as an anti-cancer treatment in metastatic breast cancer, including HER2-negative and metastatic disease…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Zoledronic acid (Zometa) (zoledronic acid)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: First or Second Line HER2-negative Breast Cancer, Metastatic Disease Without Bone Metastasis | Phase 4 | Status: COMPLETED | Results posted: 2014-02-12